163 related articles for article (PubMed ID: 30271628)
1. Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant.
Niro A; Sborgia G; Sborgia A; Sborgia L; Furino C; Recchimurzo N; Alessio G
J Ophthalmol; 2018; 2018():5604632. PubMed ID: 30271628
[TBL] [Abstract][Full Text] [Related]
2. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
4. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
[TBL] [Abstract][Full Text] [Related]
5. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
6. Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex®) in macular edema due to retinal vein occlusion.
Parravano M; Oddone F; Boccassini B; Giorno P; Chiaravalloti A; Tedeschi M; Scarinci F; Varano M
Ophthalmic Res; 2014; 51(3):153-60. PubMed ID: 24642474
[TBL] [Abstract][Full Text] [Related]
7. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
[TBL] [Abstract][Full Text] [Related]
8. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
[TBL] [Abstract][Full Text] [Related]
9. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
10. Vascular changes in eyes treated with dexamethasone intravitreal implant for macular edema after retinal vein occlusion.
Sadda S; Danis RP; Pappuru RR; Keane PA; Jiao J; Li XY; Whitcup SM
Ophthalmology; 2013 Jul; 120(7):1423-31. PubMed ID: 23499064
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
Lee KH; Kang EC; Koh HJ
Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
[TBL] [Abstract][Full Text] [Related]
13. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.
Yeh WS; Haller JA; Lanzetta P; Kuppermann BD; Wong TY; Mitchell P; Whitcup SM; Kowalski JW
Ophthalmology; 2012 Jun; 119(6):1190-8. PubMed ID: 22361318
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion.
Giuffrè C; Cicinelli MV; Marchese A; Coppola M; Parodi MB; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):787-793. PubMed ID: 31897703
[TBL] [Abstract][Full Text] [Related]
16. Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept.
Zhang Q; Hou Y; Cao X; Zhang R; Liu Y; Wei C; Wu C; Mei L; Zhang P
BMC Ophthalmol; 2021 Nov; 21(1):402. PubMed ID: 34809591
[TBL] [Abstract][Full Text] [Related]
17. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
[TBL] [Abstract][Full Text] [Related]
18. RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANT.
Danis RP; Sadda S; Jiao J; Li XY; Whitcup SM
Retina; 2016 Jun; 36(6):1170-6. PubMed ID: 26655606
[TBL] [Abstract][Full Text] [Related]
19. Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.
Winterhalter S; Eckert A; Vom Brocke GA; Schneider A; Pohlmann D; Pilger D; Joussen AM; Rehak M; Grittner U
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):267-279. PubMed ID: 29185099
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
